ADVANCES IN THE DEVELOPMENT OF VACCINE AGAINST DIFFERENT SARS CoV-2 VARIANTS

Shivangi Saxena*, Srishti Katiyar, Abhay Kumar, Archan Gupta, Shalini Yadav and Pushpendra Kumar

ABSTRACT

The coronavirus 2 that causes the severe acute respiratory syndrome, a worldwide disease that has caused devastation on public health, human lives, and the global economy. Vaccination is regarded as one of the most significant breakthroughs during medical history. Based on past SARS-CoV vaccine development experience, All COVID-19 vaccinations should be investigated for both protective advantages and potential risks eosinophilic infiltration and/or increased infectivity may come from antibody-dependent enhancement. This is regarded as the world leader in SARS-CoV-2 vaccine research, the Sinopharm CNBG initiating the most current international clinical investigation in the UAE. We discuss recent developments in vaccine research against SARS-CoV-2 clinically relevant strains, such initiatives, it is predicted, would contribute in the developments of effective and economical SARS-CoV-2 vaccine.

Keywords: .